2026 Global: Cell Surface Markers Detection Market-Competitive Review (2032) report
Description
The 2026 Global: Cell Surface Markers Detection Market-Competitive Review (2031) report features the global market size and projected growth/decline data for the period 2021 through 2032. The report primarily provides an examination of the business strategies for the ten largest global companies in the market and how their strategies differ.
Perry/Hope Partners' reports provide the most accurate industry forecasts based on our proprietary economic models. Our forecasts project the product market size nationally and by regions for 2021 to 2032 using regression analysis in our modeling. and Perry/Hope is the only market research publisher that utilizes both longitudinal (historical) and vertical (from market section to market division to market class) analysis, since we study every manufactured product in the countries we analyze. The report also provides written analysis on the market definition, market segments, and SWOT analysis (market strengths, weaknesses, opportunities, and threats).
The market study aims at estimating the market size and the growth potential of this market. Topics analyzed within the report include a detailed breakdown of the global markets for cell surface markers detection market by geography and historical trend. The scope of the report extends to sizing of the cell surface markers detection market market and global market trends with market data for 2024 as the base year, 2025 and 2026 as the estimate years with projection of CAGR from 2027 to 2032.
The report also features a list of the top ten largest global players in the market. A review of each company includes 1) an estimate of the market share, 2) a listing of the products and/or services in the market, and 3) the features of these products and/or services in the market. The report has a chapter on Comparative Business Strategies for the largest four players. An example of the Comparative Business Strategies analysis would be -- How does Netflix's business strategy to expand its market share in the global online streaming compare to Amazon Prime's business strategy through its video products and services?
The ten market players in this report and a brief synopsis of their participation in the market are:
Thermo Fisher Scientific Inc., Becton Dickinson and Company, and Danaher Corporation lead the Cell Surface Markers Detection Market, followed by Bio-Rad Laboratories, Abbott Laboratories, and others driving innovation through advanced flow cytometry and reagents.
Thermo Fisher Scientific Inc. dominates with its expansive portfolio of reagents, flow cytometry platforms, and robust supply chain, enabling clinical and research applications in immunophenotyping and personalized medicine. The company pursues organic and inorganic growth via acquisitions and expansions to maintain leadership. Becton Dickinson and Company (BD) excels in automated systems and diagnostic tools, leveraging global distribution for high-throughput cell analysis in oncology and immunology. Danaher Corporation, via subsidiaries like Beckman Coulter, delivers precision immunocytochemistry and flow cytometry products, bolstered by strategic alliances and mergers to enhance targeted therapies. Bio-Rad Laboratories provides monoclonal antibodies and assay platforms for reliable oncology and immunology studies, emphasizing quality control and workflow integration.
Abbott Laboratories contributes diagnostic solutions amid rising chronic disease demands, while Abcam plc offers a vast antibody catalog for immuno-oncology and stem cell research, supported by digital tools and reproducibility focus. Sysmex Corporation and Nihon Kohden Corporation advance hematology analyzers for cell profiling, with Sysmex leading in clinical diagnostics through innovative open-vial models. Bio-Techne Corporation specializes in multiplexed kits for cell therapy, and Agilent Technologies provides analytical systems with automation for high-throughput reproducibility. These firms consolidate the moderately fragmented market via R&D investments, product launches like Beckman Coulter's CellMek SPS, and geographical expansions, projecting growth to USD 5.90 billion globally in 2025.
PerkinElmer Inc. integrates immunoassay imaging for sensitive detection, Sartorius AG streamlines workflows with automated instruments, and additional players like F. Hoffmann-La Roche, QIAGEN N.V., and BioLegend expand multiplexing and precision capabilities. Mergers, such as those by Danaher and Thermo Fisher, strengthen portfolios amid demands for integrated software-reagent solutions. North America holds dominance due to infrastructure and launches, with Asia-Pacific rising via investments in China. Overall, these ten—Thermo Fisher, BD, Danaher, Bio-Rad, Abbott, Abcam, Sysmex, Bio-Techne, Agilent, Sartorius—fuel a market characterized by technological advancements and strategic collaborations.
Perry/Hope Partners' reports provide the most accurate industry forecasts based on our proprietary economic models. Our forecasts project the product market size nationally and by regions for 2021 to 2032 using regression analysis in our modeling. and Perry/Hope is the only market research publisher that utilizes both longitudinal (historical) and vertical (from market section to market division to market class) analysis, since we study every manufactured product in the countries we analyze. The report also provides written analysis on the market definition, market segments, and SWOT analysis (market strengths, weaknesses, opportunities, and threats).
The market study aims at estimating the market size and the growth potential of this market. Topics analyzed within the report include a detailed breakdown of the global markets for cell surface markers detection market by geography and historical trend. The scope of the report extends to sizing of the cell surface markers detection market market and global market trends with market data for 2024 as the base year, 2025 and 2026 as the estimate years with projection of CAGR from 2027 to 2032.
The report also features a list of the top ten largest global players in the market. A review of each company includes 1) an estimate of the market share, 2) a listing of the products and/or services in the market, and 3) the features of these products and/or services in the market. The report has a chapter on Comparative Business Strategies for the largest four players. An example of the Comparative Business Strategies analysis would be -- How does Netflix's business strategy to expand its market share in the global online streaming compare to Amazon Prime's business strategy through its video products and services?
The ten market players in this report and a brief synopsis of their participation in the market are:
Thermo Fisher Scientific Inc., Becton Dickinson and Company, and Danaher Corporation lead the Cell Surface Markers Detection Market, followed by Bio-Rad Laboratories, Abbott Laboratories, and others driving innovation through advanced flow cytometry and reagents.
Thermo Fisher Scientific Inc. dominates with its expansive portfolio of reagents, flow cytometry platforms, and robust supply chain, enabling clinical and research applications in immunophenotyping and personalized medicine. The company pursues organic and inorganic growth via acquisitions and expansions to maintain leadership. Becton Dickinson and Company (BD) excels in automated systems and diagnostic tools, leveraging global distribution for high-throughput cell analysis in oncology and immunology. Danaher Corporation, via subsidiaries like Beckman Coulter, delivers precision immunocytochemistry and flow cytometry products, bolstered by strategic alliances and mergers to enhance targeted therapies. Bio-Rad Laboratories provides monoclonal antibodies and assay platforms for reliable oncology and immunology studies, emphasizing quality control and workflow integration.
Abbott Laboratories contributes diagnostic solutions amid rising chronic disease demands, while Abcam plc offers a vast antibody catalog for immuno-oncology and stem cell research, supported by digital tools and reproducibility focus. Sysmex Corporation and Nihon Kohden Corporation advance hematology analyzers for cell profiling, with Sysmex leading in clinical diagnostics through innovative open-vial models. Bio-Techne Corporation specializes in multiplexed kits for cell therapy, and Agilent Technologies provides analytical systems with automation for high-throughput reproducibility. These firms consolidate the moderately fragmented market via R&D investments, product launches like Beckman Coulter's CellMek SPS, and geographical expansions, projecting growth to USD 5.90 billion globally in 2025.
PerkinElmer Inc. integrates immunoassay imaging for sensitive detection, Sartorius AG streamlines workflows with automated instruments, and additional players like F. Hoffmann-La Roche, QIAGEN N.V., and BioLegend expand multiplexing and precision capabilities. Mergers, such as those by Danaher and Thermo Fisher, strengthen portfolios amid demands for integrated software-reagent solutions. North America holds dominance due to infrastructure and launches, with Asia-Pacific rising via investments in China. Overall, these ten—Thermo Fisher, BD, Danaher, Bio-Rad, Abbott, Abcam, Sysmex, Bio-Techne, Agilent, Sartorius—fuel a market characterized by technological advancements and strategic collaborations.
Table of Contents
32 Pages
- 1.0 Scope of Report and Methodology
- 2.0 Market SWOT Analysis and Players
- 2.1 Market Definition
- 2.2 Market Segments
- 2.3 Market Strengths
- 2.4 Market Weaknesses
- 2.5 Market Threats
- 2.6 Market Opportunities
- 2.7 Major Players
- 3.0 Competitive Analysis
- 3.1 Market Player 1
- 3.2 Market Player 2
- 3.3 Market Player 3
- 3.4 Market Player 4
- 3.5 Market Player 5
- 3.6 Market Player 6
- 3.7 Market Player 7
- 3.8 Market Player 8
- 3.9 Market Player 9
- 3.10 Market Player 10
- 4.0 Comparative Business Strategies
- 4.1 Comparative Business Strategies of Player 1 and 2
- 4.2 Comparative Business Strategies of Player 1 and 3
- 4.3 Comparative Business Strategies of Player 1 and 4
- 4.4 Comparative Business Strategies of Player 2 and 3
- 4.5 Comparative Business Strategies of Player 2 and 4
- 4.6 Comparative Business Strategies of Player 3 and 4
- 5.0 Appendix
Search Inside Report
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.